Product Information
DESCOVY 200-25 MG TABLET is a brand product labeled by Gilead Sciences, Inc., priced at $71.4409 per EA under NDC 61958200201. Its NADAC has been published 515 times since Aug 17, 2016.
Strength
200; 25 mg/1; mg/1
Manufacturer
Gilead Sciences, Inc.NDC
61958200201
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATEApproval Type
New Drug (NDA)
FDA Application
NDA208215On Market Since
4/4/2016
Pharmacological Classes
Price Statistics
The NADAC for DESCOVY 200-25 MG TABLET has been published 515 times since Aug 17, 2016, and over the history we have for it it has risen 52.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $71.4409 per EA |
|---|---|
| All-time high | $71.4409 (Jun 24, 2026) |
| All-time low | $46.8885 (Sep 21, 2016) |
| 52-week high | $71.4409 |
| 52-week low | $71.2856 |
| Median price | $62.5319 |
| Average price | $62.1765 |
| Largest weekly change | +6.9% (Jan 10, 2018) |
| Weeks tracked | 515 |
| Tracking since | Aug 17, 2016 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DESCOVY 200-25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DESCOVY 200-25 MG TABLET, manufactured by Gilead Sciences, Inc., is $71.4409 per EA (NDC 61958200201), effective Jun 24, 2026.
How has the price of DESCOVY 200-25 MG TABLET changed over time?
Over the history we have for it, the NADAC for DESCOVY 200-25 MG TABLET has risen 52.0%. It has been tracked across 515 weekly CMS publications since Aug 17, 2016.
What are the highest and lowest recorded NADAC prices for DESCOVY 200-25 MG TABLET?
Since Aug 17, 2016, the NADAC for DESCOVY 200-25 MG TABLET has ranged from a low of $46.8885 (Sep 21, 2016) to a high of $71.4409 (Jun 24, 2026), with a median of $62.5319 per EA.
Are there cheaper alternatives to DESCOVY 200-25 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as DESCOVY 200-25 MG TABLET, but none are currently priced below it.
Who manufactures DESCOVY 200-25 MG TABLET?
DESCOVY 200-25 MG TABLET (NDC 61958200201) is labeled by Gilead Sciences, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification